Found: 76
Select item for more details and to access through your institution.
Suramin toxicity and efficacy in agnogenic myeloid metaplasia.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 127, doi. 10.1007/s10637-024-01420-8
- By:
- Publication type:
- Article
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 115, doi. 10.1007/s10637-021-01175-6
- By:
- Publication type:
- Article
Neuroprotection mediated by inhibition of calpain during acute viral encephalitis.
- Published in:
- Scientific Reports, 2016, p. 28699, doi. 10.1038/srep28699
- By:
- Publication type:
- Article
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Inhibiting the Growth of Pancreatic Adenocarcinoma <i>In Vitro</i> and <i>In Vivo</i> through Targeted Treatment with Designer Gold Nanotherapeutics.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0057522
- By:
- Publication type:
- Article
Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024374
- By:
- Publication type:
- Article
Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 6, p. 638, doi. 10.1067/mcp.2002.129502
- By:
- Publication type:
- Article
Combined local delivery of tacrolimus and stem cells in hydrogel for enhancing peripheral nerve regeneration.
- Published in:
- Biotechnology & Bioengineering, 2021, v. 118, n. 7, p. 2804, doi. 10.1002/bit.27799
- By:
- Publication type:
- Article
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66545-5
- By:
- Publication type:
- Article
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1137, doi. 10.3390/cancers16061137
- By:
- Publication type:
- Article
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1050, doi. 10.3390/cancers16051050
- By:
- Publication type:
- Article
Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside.
- Published in:
- Endocrinology, 2021, v. 162, n. 12, p. 1, doi. 10.1210/endocr/bqab191
- By:
- Publication type:
- Article
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 495, doi. 10.1007/s10637-005-2910-4
- By:
- Publication type:
- Article
Corticosteroid and Cortisol Serum Levels Following Intra‐articular Triamcinolone Acetonide Lumbar Facet Joint Injections.
- Published in:
- Pain Practice, 2018, v. 18, n. 7, p. 864, doi. 10.1111/papr.12686
- By:
- Publication type:
- Article
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21229, doi. 10.1002/cam4.6701
- By:
- Publication type:
- Article
Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231841
- By:
- Publication type:
- Article
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Irinotecan in the treatment of glioma patients (These studies are being conducted as a collaborative effort of the North Central Cancer Treatment Group, Mayo Clinic, and Pharmacia Corporation.).
- Published in:
- Cancer (0008543X), 2003, v. 97, p. 2352
- By:
- Publication type:
- Article
Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications.
- Published in:
- Annals of Neurology, 2021, v. 90, n. 6, p. 887, doi. 10.1002/ana.26245
- By:
- Publication type:
- Article
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 219, doi. 10.1002/cpt.1359
- By:
- Publication type:
- Article
Mouse pharmacokinetics and metabolism of the phenylurea thiocarbamate NSC 161128.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 359, doi. 10.1007/s00280-021-04295-1
- By:
- Publication type:
- Article
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 829, doi. 10.1007/s00280-020-04171-4
- By:
- Publication type:
- Article
Pharmacokinetics of dacarbazine (DTIC) in pregnancy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 39, doi. 10.1007/s00280-007-0443-6
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 461, doi. 10.1007/s00280-006-0285-7
- By:
- Publication type:
- Article
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 207, doi. 10.1007/s00280-006-0259-9
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 6, p. 522, doi. 10.1007/s00280-004-0950-7
- By:
- Publication type:
- Article
Single-dose pharmacokinetics of the DNA-binding bioreductive agent NLCQ-1 (NSC 709257) in CD2F<sub>1</sub> mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 51, n. 6, p. 483, doi. 10.1007/s00280-003-0570-7
- By:
- Publication type:
- Article
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac073
- By:
- Publication type:
- Article
Controlled Delivery of Vancomycin via Charged Hydrogels.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146401
- By:
- Publication type:
- Article
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 11, p. 1303, doi. 10.1002/jcph.543
- By:
- Publication type:
- Article
Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 4, p. 403, doi. 10.1002/jcph.26
- By:
- Publication type:
- Article
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30938
- By:
- Publication type:
- Article
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 3, p. 1, doi. 10.1002/pbc.30817
- By:
- Publication type:
- Article
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 12, p. 1, doi. 10.1002/pbc.30672
- By:
- Publication type:
- Article
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515).
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 9, p. 1, doi. 10.1002/pbc.29065
- By:
- Publication type:
- Article
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase‐Clinical Trial Network (PEP‐CTN).
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28892
- By:
- Publication type:
- Article
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 10, p. 1717, doi. 10.1002/pbc.25575
- By:
- Publication type:
- Article
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 7, p. 1246, doi. 10.1002/pbc.25023
- By:
- Publication type:
- Article